A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Adalimumab
Related studies linked through entity extraction aliases.
A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Status
- RECRUITING
- Phase
- PHASE3
Effects of TNF Blockade on Human BPH/LUTS
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Status
- RECRUITING
- Phase
- PHASE4
Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
- Status
- RECRUITING
- Phase
- PHASE2
Therapeutic Monitoring of Infliximab and Adalimumab
- Status
- UNKNOWN
- Phase
- N/A
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
- Status
- RECRUITING
- Phase
- PHASE3
Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge
- Status
- COMPLETED
- Phase
- PHASE1
"Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease"
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease
- Status
- RECRUITING
- Phase
- N/A
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Yuflyma® (Adalimumab), Patient Experience After Switching
- Status
- UNKNOWN
- Phase
- N/A